Relationship between endothelial dysfunction, carotid artery intima media thickness and circulating markers of vascular inflammation in obese hypertensive children and adolescents

Journal of Pediatric Endocrinology and Metabolism

Volumn 20, Issue 10, 2007, Pages 1125-1136

  Głowińska Olszewska, Barbara ^a   Tołwińska, Joanna ^a   Urban, Mirosława ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Adhesion molecules; Children; Endothelial dysfunction; FMD; IMT

Indexed keywords

ADHESIN; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1;

ADOLESCENT; ADULT; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTERY INTIMA; ARTERY MEDIA; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CAROTID ARTERY DISEASE; COMMON CAROTID ARTERY; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE MARKER; DISEASE PREDISPOSITION; ECHOGRAPHY; ENDOTHELIAL DYSFUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERTENSION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OBESITY; PATHOGENESIS; REGRESSION ANALYSIS; SCHOOL CHILD; STATISTICAL SIGNIFICANCE;

EID: 36348945836     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2007.20.10.1125     Document Type: Article

References (41)

1. Behrendt D, Ganz P. Endothelial function; From vascular biology to clinical applications. Am J Cardiol 2002; 90: 40L-48L.
2. Celermajer DS. Noninvasive detection of atherosclerosis. N Engl J Med 1998; 339: 2014-2015.
3. Widlansky ME, Gokce N, Keaney JF Jr, Vita JA. The clinical implications of endothelial dysfunction. J Am Coll Cardiol 2003; 42: 1149-1160.
4. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135-1143.
5. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999; 340:115-126.
6. Blake GJ, Ridker PM. Novel clinical markers of vascular wall inflammation. Circ Res 2001; 89: 763-771.
7. Huang AL, Vita JA. Effects of systemic inflammation on endothelium-dependent vasodilation. Trends Cardiovasc Med 2006; 16: 15-20.
8. Blankenberg S, Barbaux S, Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis 2003; 170: 191-203.
9. Blann AD, Lip GY. The endothelium in atherothromboric disease: assessment of function, mechanisms and clinical implications. Blood Coagul Fibrinolysis 1998; 9: 297-306.
10. Hillis GS, Flapan AD. Cell adhesion molecules in cardiovascular disease: a clinical perspective. Heart 1998; 79: 429-431.
11. Slyper AH. Clinical review 168: What vascular ultrasound testing has revealed about pediatric atherogenesis, and a potential clinical role for ultrasound in pediatric risk assessment. J Clin Endocrinol Metab 2004; 89: 3089-3095.
12. Rembold KE, Ayers CR, Wills MB, Rembold CM. Usefulness of carotid intimal medial thickness and flow-mediated dilation in a preventive cardiovascular practice. Am J Cardiol 2003; 91: 1475-1477.
13. Glowinska B, Urban M, Peczynska J, Florys B. Soluble adhesion moleclues (sICAM-1, sVCAM-1) and selectines (sE-selectin, sP-selectin, sL-selectin) levels in children and adolescents with obesity, hypertension and diabetes. Metabolism 2005; 54: 1020-1026.
14. Palczewska I, Niedzwiedzka Z. Somatic development indices in children and youth of Warsaw. Med Wieku Rozwoj 2001; 5: 18-118.
15. Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents. Pediatrics 1996; 98: 649-658.
16. Radziuk J. Insulin sensivity and its measurement: structural commonalities among the methods. J Clin Endocrinol Metab 2000; 85: 4426-4433.
17. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111-1115.
18. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986; 74: 1399-1406.
19. Reinehr T, Kiess W, de Sousa G, Stoffel-Wagner B, Wunsch R. Intima media thickness in childhood obesity: relations to inflammatory marker, glucose metabolism, and blood pressure. Metabolism 2006; 55: 113-118.
20. Jarvisalo MJ, Raitakari M, Toikka JO, Putto-Laurila A, Rontu R, Laine S, Lehtimaki T, Ronnemaa T, Viikari J, Raitakari OT. Endothelial dysfunction and increased arterial intima-media thickness in children with type 1 diabetes. Circulation 2004; 109: 1750-1755.
21. Singh TP, Groehn H, Kazmers A. Vascular function and carotid intimal-medial thickness in children with insulin-dependent diabetes mellitus. J Am Coll Cardiol 2003; 41: 661-665.
22. Jarvisalo MJ, Harmoinen A, Hakanen M, Paakkunainen U, Viikari J, Hartiala J, Lehtimaki T, Simell O, Raitakari OT. Elevated serum C-reactive protein levels and early arterial changes in healthy children. Arterioscler Thromb Vasc Biol 2002; 22: 1323-1328.
23. Vita JA, Keaney JF Jr. Endothelial function: a barometer for cardiovascular risk? Circulation 2002; 106: 640-642.
24. Witte DR, Broekmans WM, Kardinaal AF, Klopping-Ketelaars IA, van Poppel G, Bots ML, Kluft C, Princen JM. Soluble intercellular adhesion molecule 1 and flow-mediated dilatation are related to the estimated risk of coronary heart disease independently from each other. Atherosclerosis 2003; 170: 147-153.
25. Holmlund A, Hulthe J, Millgard J, Sarabi M, Kahan T, Lind L. Soluble intercellular adhesion molecule-1 is related to endothelial vasodilatory function in healthy individuals. Atherosclerosis 2002; 165: 271-276.
26. Głowinska-Olszewska B, Urban M, Tołwinska J, Peczyńska J, Florys B. Correlation analysis between biochemical and biophysical markers of endothelium damage in children with diabetes type 1. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw 2005; 11: 221-227.
27. Rizzoni D, Muiesan ML, Porteri E, Castellano M, Salvetti M, Monteduro C, de Ciuceis C, Boari G, Valentini U, Cimino A, Sleiman I, Agabiti-Rosei E. Circulating adhesion molecules and carotid artery structural changes in patients with noninsulin-dependent diabetes mellitus. J Hum Hypertens 2003; 17: 463-470.
28. Berenson GS, Srinivasan SR, Bao W, Newman WP 3rd, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 1998; 338: 1650-1656.
29. Hwang SJ, Ballantyne CM, Sharrett AR, Smith LC, Davis CE, Gotto AM Jr, Boerwinkle E. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation 1997; 96: 4219-4225.
30. Rohde LE, Lee RT, Rivero J, Jamacochian M, Arroyo LH, Briggs W, Rifai N, Libby P, Creager MA, Ridker PM. Circulating cell adhesion molecules are correlated with ultrasound-based assessment of carotid atherosclerosis. Arterioscler Thromb Vasc Biol 1998; 18: 1765-1770.
31. Kondo K, Kitagawa K, Nagai Y, Yamagami H, Hashimoto H, Hougaku H, Hori M. Associations of soluble intercellular adhesion molecule-1 with carotid atherosclerosis progression. Atherosclerosis 2005; 179: 155-160.
32. Blann AD, Lip GY. Endothelial integrity, soluble adhesion molecules and platelet markers in type 1 diabetes mellitus. Diabet Med 1998; 15: 634-642.
33. Cominacini L, Fratta Pasini A, Garbin U, Davoli A, De Santis A, Campagnola M, Rigoni A, Zenti MG, Moghetti P, Lo Cascio V. Elevated levels of soluble E-selectin in patients with IDDM and NIDDM: relation to metabolic control. Diabetologia 1995; 38:1122-1124.
34. de Lemos JA, Hennekens CH, Ridker PM. Plasma concentration of soluble vascular cell adhesion molecule-1 and subsequent cardiovascular risk. J Am Coll Cardiol 2000; 36: 423-426.
35. Davies MJ, Gordon JL, Gearing AJ, Pigott R, Woolf N, Katz D, Kyriakopoulos A. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J Pathol 1993; 171: 223-229.
36. Leinonen E, Hurt-Camejo E, Wiklund O, Hulten LM, Hiukka A, Taskinen MR. Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes. Atherosclerosis 2003; 166: 387-394.
37. Balletshofer BM, Rittig K, Stock J, Leim-Stefan A, Overkamp D, Dietz K, Haring HU. Insulin resistant young subjects at risk of accelerated atherosclerosis exhibit a marked reduction in peripheral endothelial function early in life but not differences in intima-media thickness. Atherosclerosis 2003; 171: 303-309.
38. Suzuki M, Takamisawa I, Suzuki K, Hiuge A, Horio T, Yoshimasa Y, Harano Y. Close association of endothelial dysfunction with insulin resistance and carotid wall thickening in hypertension. Am J Hypertens 2004; 17: 228-232.
39. Zavaroni I, Ardigo D, Zuccarelli A, Pacetti E, Piatti PM, Monti L, Valtuena S, Massironi P, Rossi PC, Reaven GM. Insulin resistance/ compensatory hyperinsulinemia predict carotid intimal medial thickness in patients with essential hypertension. Nutr Metab Cardiovasc Dis 2006; 16: 22-27.
40. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest 1994; 94: 1172-1179.
41. Cardillo C, Nambi SS, Kilcoyne CM, Choucair WK, Katz A, Quon MJ, Panza JA. Insulin stimulates both endothelin and nitric oxide activity in the human forearm. Circulation 1999; 100: 820-825.